000 01447 a2200325 4500
005 20250514180906.0
264 0 _c20041230
008 200412s 0 0 eng d
022 _a1567-5769
024 7 _a10.1016/j.intimp.2003.10.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerrero, Simone
245 0 0 _aMatalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines [Int Immunopharmacol 2003; 3(1):81-89].
_h[electronic resource]
260 _bInternational immunopharmacology
_cJan 2004
300 _a157-8; author reply 159-60 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBlood Chemical Analysis
650 0 4 _aBlood Specimen Collection
650 0 4 _aDanazol
_xtherapeutic use
650 0 4 _aEndometriosis
_xblood
650 0 4 _aEstrogen Antagonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeuprolide
_xtherapeutic use
650 0 4 _aPlatelet Count
650 0 4 _aVascular Endothelial Growth Factors
_xblood
773 0 _tInternational immunopharmacology
_gvol. 4
_gno. 1
_gp. 157-8; author reply 159-60
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2003.10.008
_zAvailable from publisher's website
999 _c14697001
_d14697001